[Prevalence of anal diseases after Scopinaro's biliopancreatic bypass for super-obese patients]
- PMID: 18783671
- DOI: 10.1016/s0009-739x(08)72154-7
[Prevalence of anal diseases after Scopinaro's biliopancreatic bypass for super-obese patients]
Abstract
Introduction: Biliopancreatic diversion by Scopinaro (BD) is a mixed (malabsortive and restrictive) bariatric technique that is successful in achieving long lasting weight lost in super obese patients. In fact, the diarrhoea (steatorrhea) that is expected after any malabsortive technique can sometimes cause significant nutritional changes and anal disease: these patients are frequently referred to our coloproctology outpatient clinic due to haemorrhoids, fissures, anal sepsis and fistula basically due to changes in quality and quantity of their faeces. The aim of this paper is to find out not only the prevalence of anal disease in our series of super obese surgical patients but also to compare the incidence between the two surgical techniques we perform in our department.
Material and method: We analyzed 263 consecutive patients operated on BD of Scopinaro (50-200 cm) and modified-BD (75-225 cm) in our Department. Patients who had previously suffered from anal surgery were excluded.
Results: There were 45 patients (18%) who suffered from anal problems of which 38 cases (84.4%) were BD-S and only 7 cases with BD-M complained of anal disorders (p < 0.05). Overall, at the 18th month review, the mean number of motions per day was 3.5 (range, 1-15). Patients with BD-S had 5 motions per day as a mean. The mean number of motions for BD-M was 2. The frequency order of anal pathology observed was: anal fissure, haemorrhoids, abscess and fistula.
Conclusions: Higher incidence of anal pathology after BD of Scopinaro is another factor to take into account to avoid performing classic Scopinaro BD as opposed to modified BD for the treatment of morbid super obesity. It is mandatory to be conservative when facing anal problems in these patients, and firstly we must modify eating habits and the nutritional status. Surgery must be highly respectful to anal sphincters to avoid incontinence.
Similar articles
-
Botulinum toxin for chronic anal fissure after biliopancreatic diversion for morbid obesity.World J Gastroenterol. 2012 Mar 14;18(10):1021-7. doi: 10.3748/wjg.v18.i10.1021. World J Gastroenterol. 2012. PMID: 22416176 Free PMC article.
-
Effect of bismuth subgallate on the quality of life in patients undergoing Scopinaro's biliopancreatic diversion.Surg Obes Relat Dis. 2015 Mar-Apr;11(2):436-41. doi: 10.1016/j.soard.2014.10.024. Epub 2014 Nov 11. Surg Obes Relat Dis. 2015. PMID: 25820078
-
[Preliminary results of biliopancreatic diversion in the treatment of morbid obesity. Clinical considerations on 69 patients with a 3-year follow-up].Minerva Chir. 2000 Apr;55(4):211-9. Minerva Chir. 2000. PMID: 10859954 Italian.
-
Biliopancreatic diversion in the surgical treatment of morbid obesity.World J Surg. 2004 May;28(5):435-44. doi: 10.1007/s00268-004-7364-x. Epub 2004 Apr 19. World J Surg. 2004. PMID: 15085390 Review.
-
[From bariatric to metabolic surgery: 15 years experience in a French university hospital].Bull Acad Natl Med. 2010 Jan;194(1):25-36; discussion 36-8. Bull Acad Natl Med. 2010. PMID: 20669557 Review. French.
Cited by
-
Benign Anorectal Disorders and Pelvic Floor Disease After Bariatric Surgery.J Clin Med Res. 2022 Jul;14(7):260-263. doi: 10.14740/jocmr4713. Epub 2022 Jun 2. J Clin Med Res. 2022. PMID: 35974804 Free PMC article. Review.
-
Segmental internal sphincterotomy--a new technique for treatment of chronic anal fissure.J Gastrointest Surg. 2011 Dec;15(12):2271-4. doi: 10.1007/s11605-011-1689-1. Epub 2011 Sep 27. J Gastrointest Surg. 2011. PMID: 21948181
-
Botulinum toxin for chronic anal fissure after biliopancreatic diversion for morbid obesity.World J Gastroenterol. 2012 Mar 14;18(10):1021-7. doi: 10.3748/wjg.v18.i10.1021. World J Gastroenterol. 2012. PMID: 22416176 Free PMC article.
-
Identifying the best therapy for chronic anal fissure.World J Gastrointest Pharmacol Ther. 2011 Apr 6;2(2):9-16. doi: 10.4292/wjgpt.v2.i2.9. World J Gastrointest Pharmacol Ther. 2011. PMID: 21577312 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical